SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-000014
Filing Date
2023-01-03
Accepted
2023-01-03 06:10:18
Documents
1
Period of Report
2022-12-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3942
  Complete submission text file 0001493152-23-000014.txt   5333
Mailing Address ONE RESEARCH COURT SUITE 450 ROCKVILLE MD 20850
Business Address ONE RESEARCH COURT SUITE 450 ROCKVILLE MD 20850 2404034212
Shuttle Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001757499 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SHUTTLE PHARMACEUTICALS HOLDINGS, INC. ONE RESEARCH COURT, SUITE 450 ROCKVILLE MD 20850
Business Address
Rich Tyvin (Reporting) CIK: 0001945208 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41488 | Film No.: 23500079